sar
coronaviru
sarscov
emerg
import
caus
sever
lower
respiratori
tract
infect
human
vitro
model
lung
need
elucid
cellular
target
consequ
viral
infect
sever
sudden
onset
symptom
result
atyp
pneumonia
dri
cough
persist
high
fever
case
sever
acut
respiratori
viru
brought
light
import
coronavirus
potenti
lethal
human
pathogen
identif
sever
zoonot
reservoir
made
reemerg
new
strain
futur
epidem
possibl
chapter
describ
patholog
sarscov
infect
human
explor
use
two
model
human
conduct
airway
develop
better
understand
replic
pathogenesi
sarscov
relev
vitro
system
first
cultur
model
human
bronchial
epitheli
cell
line
inocul
virus
either
nonpolar
monolay
cell
polar
cell
tight
junction
microvilli
second
model
system
deriv
primari
cell
isol
human
airway
epithelium
grown
transwel
form
pseudostratifi
mucociliari
epithelium
recapitul
morpholog
physiolog
featur
human
conduct
airway
vivo
experiment
result
use
lung
epitheli
cell
model
demonstr
contrast
patholog
report
late
stage
case
sarscov
replic
high
titer
epitheli
cell
conduct
airway
sarscov
receptor
human
angiotensin
convert
enzym
detect
exclus
apic
surfac
cell
polar
cell
human
airway
epitheli
cultur
hae
indic
access
sarscov
airway
lumen
deliveri
furthermor
hae
exclus
local
ciliat
airway
epitheli
cell
support
local
data
product
rout
inocul
progeni
virion
egress
polar
ciliat
cell
hae
apic
surfac
suggest
mechan
releas
larg
quantiti
viru
lumen
human
lung
preincub
apic
surfac
cultur
antisera
direct
reduc
viral
titer
log
antisera
dcsigndcsignr
reduc
viral
replic
level
suggest
primari
receptor
entri
sarscov
ciliat
cell
hae
cultur
assess
infect
ciliat
airway
cultur
deriv
suscept
anim
speci
gener
recombin
sarscov
delet
open
read
frame
orf
insert
green
fluoresc
protein
gfp
result
sarscov
gfp
sarscov
gfp
replic
similar
titer
wild
type
virus
vero
cell
addit
sarscov
replic
airway
epitheli
cultur
gener
publish
disclaim
pdf
file
unedit
manuscript
accept
public
servic
custom
golden
syrian
hamster
trachea
reach
similar
titer
human
cultur
hour
post
infect
effici
sarscov
infect
ciliat
celltyp
hae
provid
use
vitro
model
human
lung
origin
studi
characterist
sarscov
replic
pathogenesi
import
human
coronavirus
hcov
pathogen
produc
sever
human
respiratori
diseas
greatli
emphas
identif
sarscov
relev
model
system
need
elucid
underli
molecular
mechan
govern
coronaviru
pathogenesi
virul
human
lung
sarscov
infect
attract
model
hcov
infect
produc
sever
diseas
human
lung
replic
effici
vitro
revers
genet
system
avail
identifi
genet
determin
govern
pathogenesi
virul
varieti
anim
model
develop
almazan
et
al
lawler
et
al
martina
et
al
mccray
et
al
osterhau
et
al
robert
et
al
robert
et
al
tseng
et
al
yount
et
al
articl
provid
brief
review
patholog
sarscov
infect
well
review
research
examin
human
coronaviru
infect
vitro
model
human
conduct
airway
final
extend
current
data
character
sarscov
infect
vitro
cultur
system
human
airway
epithelium
hae
recapitul
morpholog
physiolog
featur
human
conduct
airway
vivo
determin
whether
infect
spread
sarscov
throughout
ciliat
conduct
airway
may
valid
model
understand
pathogenesi
sarscov
lung
diseas
sarscov
caus
case
death
worldwid
overal
mortal
rate
prior
success
contain
epidem
mortal
rate
follow
sarscov
infect
approach
year
age
age
age
survivor
develop
lung
cardiac
complic
han
et
al
diseas
caus
pathogen
human
coronaviru
stark
contrast
seen
strain
produc
mild
common
cold
symptom
although
seriou
diseas
report
infant
individu
underli
comorbid
pene
et
al
sarscov
isol
human
civet
cat
raccoon
dog
swine
bat
suggest
sever
anim
speci
may
function
natur
reservoir
futur
outbreak
guan
et
al
chines
horsesho
bat
abund
across
southeast
asia
probabl
natur
reservoir
sarscov
guan
et
al
li
et
al
poon
et
al
importantli
bat
bat
product
use
food
tradit
medicin
market
southern
china
asia
bat
fece
use
tradit
chines
medicin
provid
constant
sourc
human
exposur
bat
bat
tissu
make
futur
sar
sarslik
outbreak
like
fujita
sarscov
epidem
best
character
term
chang
like
evolv
follow
initi
introduct
mildli
virul
zoonot
strain
human
popul
moder
highli
virul
isol
circul
around
world
less
six
month
chines
predomin
patholog
featur
sarscov
infect
human
lung
includ
diffus
alveolar
damag
dad
atyp
pneumonia
dri
cough
persist
fever
progress
dyspnea
sometim
abrupt
deterior
lung
function
major
patholog
lesion
includ
inflammatori
exud
alveoli
interstiti
tissu
hyperplasia
fibrou
tissu
fibrosi
repres
major
histolog
chang
associ
acut
respiratori
distress
syndrom
ard
high
mortal
rate
treatment
option
ksiazek
et
al
kuiken
et
al
nichol
peiri
increas
age
male
sex
presenc
comorbid
high
earli
viral
rna
burden
high
lactat
dehydrogenas
ldh
level
associ
greater
risk
death
chu
et
al
leung
chiu
use
fluoresc
insitu
hybrid
tissu
fatal
case
diseas
viru
local
within
alveolar
pneumocyt
primarili
type
ii
within
alveolar
space
previous
report
receptor
sarscov
angiotensin
convert
enzym
local
alveolar
cell
lung
although
recent
evid
indic
present
throughout
human
airway
epithelium
suggest
addit
cellular
target
infect
jia
et
al
sarscov
specif
rna
also
local
pulmonari
macrophag
although
whether
viabl
viru
present
determin
lu
et
al
anoth
studi
base
six
patient
die
sar
pronounc
morpholog
featur
giant
cell
format
predomin
macrophag
pneumocyt
hyperplasia
suggest
proinflammatori
cytokin
releas
stimul
macrophag
alveolu
predomin
caus
pathogenesi
nichol
et
al
nichol
et
al
histolog
sampl
determin
sarscov
infect
airway
less
rigor
studi
patholog
analys
usual
perform
late
stage
fatal
case
chow
et
al
howev
earli
diseas
note
mark
bronchiolar
diseas
respiratori
epitheli
cell
necrosi
loss
cilia
squamou
metaplasia
intrabronchiolar
fibrin
deposit
fact
suggest
earli
dad
result
sarscov
infect
may
initi
within
respiratori
bronchiol
frank
et
al
nichol
et
al
nichol
et
al
also
hypothes
sarscov
replic
human
conduct
airway
may
cell
type
restrict
express
receptorcoreceptor
molecul
dendrit
cellspecif
nonintegrin
dcsigndcsignr
jeffer
et
al
dcsignr
express
readili
detect
alveolar
type
ii
cell
major
cell
type
infect
fatal
case
sar
infect
vitro
replic
pathogenesi
model
human
conduct
airway
would
provid
mechan
determin
sar
coronaviru
permiss
cell
type
lung
earlier
time
post
infect
provid
clue
diseas
progress
potenti
predict
sever
diseas
outcom
sever
studi
perform
identifi
sarscov
replicationcompet
vitro
model
human
conduct
airway
epithelium
tseng
et
al
publish
first
sarscov
vitro
replic
model
use
monolay
polar
cell
tseng
et
al
cell
origin
isol
human
pulmonari
adenocarcinoma
character
noncili
human
lungbronchi
epitheli
cell
follow
inocul
monolay
cell
sarscov
replic
detect
earli
hour
post
infect
peak
titer
occur
hour
post
infect
tabl
howev
viru
induc
cytopath
effect
detect
day
post
inocul
viral
titer
result
confirm
real
time
pcr
peak
viral
rna
detect
occur
hour
post
inocul
immunofluoresc
assay
use
convalesc
human
serum
isol
sarscov
infect
patient
detect
sarscov
antigen
foci
monolay
demonstr
cell
product
infect
dual
label
immunfluoresc
detect
sarscov
antigen
primari
viral
receptor
angiotensin
convert
enzym
coloc
infect
cell
suggest
requir
sarscov
entri
cell
confirm
primari
receptor
monolay
preincub
antisera
direct
prior
inocul
pretreat
cultur
antisera
direct
irrelev
control
sera
result
dose
depend
reduct
viral
titer
suggest
sarscov
depend
entri
cell
determin
sarscov
entri
releas
cell
polar
scan
confoc
imag
mockinfect
infect
cell
taken
assembl
gener
dimension
imag
sarscov
antigen
coloc
primarili
apic
surfac
cultur
suggest
sarscov
entri
releas
may
restrict
apic
surfac
cell
examin
polar
sarscov
infect
releas
cell
cultur
transwel
membran
greater
day
gener
cultur
highli
polar
cell
connect
tight
junction
visibl
microvilli
cultur
inocul
sarscov
either
via
apic
basolater
surfac
media
harvest
apic
basolater
surfac
viral
titer
assay
inocul
apic
surfac
result
releas
viru
apic
tabl
basolater
tabl
surfac
although
viral
titer
apic
surfac
log
higher
inocul
basolater
surfac
polar
cell
product
rout
infect
studi
demonstr
sarscov
could
product
infect
bronchial
epitheli
cell
like
use
primari
receptor
entri
viru
entri
releas
product
follow
apic
rout
inocul
suggest
model
releas
larg
quantiti
viru
lumen
lung
could
explain
detect
viru
lower
airway
transmiss
uninfect
individu
tabl
howev
direct
relev
result
sarscov
pathogenesi
human
requir
relev
model
human
conduct
airway
one
recapitul
celltyp
distribut
human
conduct
airway
epithelium
replic
model
provid
clue
sarscov
replic
homogen
epitheli
cell
type
experi
requir
sophist
model
contain
multipl
cell
type
faith
repres
human
conduct
airway
epithelium
human
airway
epitheli
cell
cultur
system
hae
vitro
model
human
airway
epithelium
hae
recapitul
morpholog
physiolog
featur
human
airway
epithelium
vivo
compris
ciliat
noncili
mucinsecret
basal
epitheli
cell
pickl
et
al
zhang
et
al
first
human
coronaviru
strain
demonstr
infect
hae
hcov
strain
wang
et
al
provid
clue
potenti
rout
viral
infect
hae
first
examin
local
cellular
receptor
n
detect
exclus
apic
surfac
welldifferenti
hae
suggest
primarili
apic
rout
viral
entri
util
viru
determin
product
rout
infect
cultur
inocul
via
apic
basolater
surfac
titer
apic
surfac
wash
log
greater
follow
apic
rather
basolater
inocul
demonstr
product
rout
inocul
progeni
virion
releas
via
apic
surfac
epithelium
tabl
first
demonstr
human
coronaviru
infect
human
airway
epitheli
cell
cultur
coronaviru
infect
model
investig
identif
sarscov
first
studi
sarscov
welldifferenti
hae
focus
local
sarscov
receptor
cultur
model
polar
viru
entri
releas
jia
et
al
detect
primarili
apic
surfac
welldifferenti
hae
cultur
littl
stain
detect
basolater
surfac
contrast
undifferenti
cultur
littl
detect
stain
infect
undifferenti
cultur
result
product
viru
replic
receptor
local
coronaviru
strain
sarscov
well
differenti
hae
cultur
favor
apic
rout
viral
entri
suggest
lumen
surfac
lung
like
site
viral
entri
follow
human
infect
follow
apic
inocul
apic
releas
titer
pfuml
basolater
titer
follow
apic
inocul
peak
pfuml
tabl
similar
studi
perform
less
pathogen
viru
inocul
sarscov
onto
apic
surfac
welldifferenti
hae
product
rout
infect
also
optim
site
progeni
virion
releas
tabl
howev
studi
requir
identifi
target
cell
type
sarscov
infect
determin
primari
receptor
sarscov
entri
hae
addit
coreceptor
molecul
requir
determin
rate
virion
releas
follow
sarscov
infect
welldifferenti
hae
inocul
via
apic
surfac
sarscov
moi
strain
urbani
apic
surfac
wash
harvest
daili
total
day
post
inocul
titer
plaqu
assay
cell
plaqu
form
unit
per
ml
pfuml
per
day
plot
fig
peak
titer
shed
apic
surfac
exceed
pfuml
replic
titer
similar
observ
vero
cell
monolay
contrast
titer
obtain
jia
et
al
demonstr
sarscov
replic
could
achiev
level
detect
tradit
cell
monolay
howev
viral
titer
basolater
compart
low
peak
titer
pfuml
fig
confirm
sarscov
entri
releas
progeni
virion
predomin
occur
apic
surfac
titer
icsarscov
replic
apic
surfac
consist
higher
see
variat
replic
level
patient
code
hae
cultur
allow
matur
optim
level
cilia
ciliat
cell
code
matur
similar
length
time
differ
level
icsarscov
replic
may
reflect
variat
express
level
throughout
hae
cultur
matur
experi
current
underway
determin
optim
time
postplat
express
level
altern
viru
replic
may
influenc
presenc
human
suscept
allel
age
health
statu
donor
viral
titer
increas
hour
peak
hour
constant
hour
post
inocul
hour
post
inocul
viral
titer
decreas
two
log
remain
low
hour
hour
data
shown
suggest
hae
could
longer
support
product
infect
potenti
reflect
lack
new
cell
infect
previou
studi
use
hae
model
demonstr
common
human
respiratori
virus
eg
human
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
type
exclus
infect
ciliat
epitheli
celltyp
rais
possibl
role
celltyp
pathogenesi
respiratori
viru
infect
zhang
et
al
determin
natur
cell
type
infect
sarscov
transmiss
electron
microscopi
perform
fix
cultur
hour
post
inocul
time
point
peak
viral
replic
hae
cultur
ciliat
celltyp
hae
inocul
sarscov
contain
classic
coronaviru
cytoplasm
vesicl
fill
viral
particl
fig
b
e
f
addit
larg
number
viral
particl
seen
within
space
microvillicilia
shaft
well
airway
surfac
microenviron
asm
surround
ciliat
cell
suggest
mechan
releas
larg
quantiti
sarscov
lumen
conduct
airway
viral
replic
fig
c
e
f
immunoem
detect
structur
spike
protein
confirm
particl
detect
asm
inde
sarscov
virion
fig
therefor
sarscov
entri
replic
releas
occur
exclus
ciliat
cell
hae
jia
et
al
demonstr
exclus
apic
stain
sarscov
receptor
molecul
use
hae
model
consist
apic
infect
ciliat
cell
howev
addit
coreceptor
molecul
identifi
dcsign
dcsignr
might
contribut
sarscov
entri
hae
jeffer
et
al
marzi
et
al
yang
et
al
determin
sarscov
infect
ciliat
cell
exclus
via
interact
util
antibodi
blockad
experi
use
antisera
direct
method
previous
shown
block
interact
sarscov
cell
hae
preincub
polyclon
monoclon
antisera
direct
r
system
cocktail
monoclon
antisera
specif
dcsign
dcsignr
control
antibodi
effici
bind
apic
surfac
hae
antiteth
mucin
hour
prior
inocul
sarscov
pfucultur
apic
surfac
sampl
perform
hour
post
inocul
sampl
titer
plaqu
assay
cell
determin
viral
growth
kinet
absenc
antisera
presenc
control
antisera
sarscov
replic
titer
pfuml
fig
contrast
presenc
polyclon
antisera
alon
combin
antisera
viral
titer
reduc
least
log
monoclon
antisera
fail
effect
viral
growth
confirm
antibodi
suffici
block
sarscov
entri
ciliat
cell
antisera
direct
molecul
report
function
sarscov
coreceptor
dcsign
dcsignr
affect
infect
ciliat
cell
sarscov
although
known
whether
antibodi
steric
hinder
interact
sarscov
potenti
receptor
therefor
assess
sarscov
infect
viral
growth
kinet
suggest
predomin
receptor
use
sarscov
infect
ciliat
celltyp
hae
directli
observ
extent
kinet
sarscov
infect
conduct
airway
cultur
model
anim
speci
real
time
construct
recombin
sarscov
sarscov
gfp
express
green
fluoresc
protein
open
read
frame
gener
recombin
sarscov
gfp
f
plasmid
infecti
clone
mutat
replac
gfp
cdna
use
type
ii
restrict
enzym
approach
describ
previous
mutat
f
plasmid
confirm
sequenc
analysi
amplifi
e
coli
wild
type
plasmid
e
fragment
isol
digest
appropri
restrict
enzym
purifi
ligat
genom
length
cdna
fulllength
cdna
transcrib
genom
length
rna
coelectropor
sarscov
nucleocapsid
n
transcript
vero
cell
gfpposit
cell
detect
within
hour
transfect
clarifi
supernat
transfect
cell
pass
fresh
vero
monolay
result
viral
cytopath
effect
green
fluoresc
cell
fig
delet
obvious
affect
effici
sarscov
replic
tissu
cultur
similar
observ
tgev
mhv
gfp
insert
accessori
orf
virus
baric
sim
curti
et
al
fischer
et
al
sola
et
al
prior
evalu
five
individu
plaqu
sarscov
gfp
isol
amplifi
monitor
gfp
fluoresc
addit
sequenc
confirm
mutat
plaqu
contain
gfp
appropri
sequenc
mutat
evalu
growth
kinet
sarscov
gfp
growth
curv
gener
three
differ
mammalian
epitheli
cell
line
monolay
vero
cell
inocul
urbani
icsarscov
sarscov
gfp
moi
supernat
sampl
cultur
harvest
hour
post
inocul
titer
determin
plaqu
assay
vero
cell
fig
vero
cell
urbani
sarscov
gfp
grew
titer
pfuml
icsarscov
peak
pfu
ml
fig
cell
three
virus
grew
titer
pfuml
hour
post
inocul
fig
wherea
cell
titer
three
virus
reduc
approxim
one
log
compar
cell
fig
addit
sarscov
gfp
replic
hae
cultur
also
similar
wild
type
urbani
data
shown
overal
replac
gfp
sarscov
gfp
detriment
viru
replic
three
cell
line
evalu
hae
thu
provid
fluoresc
marker
viru
infect
replic
wildtyp
viru
level
sarscov
emerg
pathogen
whose
natur
host
chines
horsesho
bat
identifi
guan
et
al
li
et
al
poon
et
al
howev
vivo
studi
shown
sarscov
replic
mous
hamster
cat
civet
cat
ferret
nonhuman
primat
lung
li
et
al
martina
et
al
osterhau
et
al
poon
et
al
robert
et
al
robert
et
al
civet
cat
like
repres
import
reservoir
transmiss
human
guan
et
al
airway
epitheli
cell
cultur
similar
human
model
describ
deriv
suscept
speci
may
provid
import
compar
model
determin
mechan
pathogenesi
replic
effici
altern
host
moreov
avail
airway
epithelium
model
mani
differ
anim
host
may
provid
method
cultur
zoonot
pathogen
associ
human
diseas
outbreak
toward
goal
success
gener
ciliat
airway
epithelium
model
deriv
tracheobronchi
airway
epithelium
balbc
mice
mae
golden
syrian
hamster
hmae
rhesu
macaqu
rhmae
repres
data
hmae
shown
figur
ac
inocul
apic
surfac
cultur
sarscov
gfp
indic
sarscov
gfp
replic
extent
ciliat
cell
rhmae
lesser
hmae
much
lesser
extent
mae
repres
data
hmae
cultur
shown
fig
b
although
fewer
cell
infect
hae
ciliat
epitheli
celltyp
predomin
cell
target
sarscov
gfp
infect
data
shown
growth
viru
percentag
infect
cell
greatli
reduc
compar
infect
rate
viral
titer
achiev
hae
evidenc
growth
hmae
cultur
approach
titer
pfuml
fig
c
howev
rough
parallel
note
ciliat
cell
deriv
human
nonhuman
primat
hamster
mous
roughli
correl
sever
diseas
note
speci
martina
et
al
mcauliff
et
al
robert
et
al
subbarao
et
al
weingartl
et
al
also
observ
variat
anim
epitheli
cultur
suscept
infect
depend
individu
batch
cell
use
gener
cultur
model
similar
variat
seen
cultur
deriv
differ
human
sampl
regardless
term
host
suscept
sarscov
hae
robust
airway
model
studi
sarscov
replic
pathogenesi
lung
airway
epithelium
often
first
tissu
encount
lumen
human
conduct
airway
pathogen
ciliat
celltyp
major
target
common
respiratori
virus
rsv
influenza
matrosovich
et
al
thompson
et
al
zhang
et
al
zhang
et
al
well
sarscov
fig
b
c
tabl
new
emerg
virus
like
also
replic
effici
hae
cultur
provid
common
airway
model
compar
virushost
interact
site
entri
human
host
ibricev
et
al
matrosovich
et
al
cultur
sarscov
replic
high
titer
similar
detect
cell
line
vero
fig
fig
prior
infect
hae
cultur
minimum
six
week
allow
maximum
number
matur
ciliat
cell
may
explain
higher
titer
sarscov
replic
nonpolar
cultur
primari
human
airway
epitheli
cell
infect
sarscov
similar
result
obtain
jia
et
al
jia
et
al
anoth
human
coronaviru
primarili
caus
mild
upper
respiratori
tract
infect
human
shown
princip
target
ciliat
epithelium
caus
cell
morpholog
alter
dyskinesia
cilia
dysfunct
follow
hae
infect
wang
et
al
howev
shed
infect
ciliat
cell
fig
note
sarscov
infect
report
follow
infect
contrast
hcov
sarscov
infect
associ
sever
atyp
pneumonia
adult
major
patholog
find
autopsi
suggest
sarscov
involv
type
ii
pneumocyt
locat
alveoli
evidenc
detect
viral
rna
em
detect
viruslik
particl
chen
et
al
cheung
et
al
zhang
et
al
zhang
et
al
importantli
patient
die
earli
follow
sarscov
exposur
show
mark
bronchiolar
diseas
respiratori
epitheli
cell
necrosi
loss
cilia
squamou
metaplasia
intrabronchiolar
fibrin
deposit
fact
suggest
earli
diffus
alveolar
damag
consequ
sarscov
infect
may
initi
respiratori
bronchiol
frank
et
al
nichol
et
al
data
present
support
hypothesi
sarscov
effici
infect
replic
ciliat
airway
cell
concomitantli
express
principl
sarscov
receptor
notabl
antibodi
effici
block
infect
replic
spread
sarscov
hae
fig
similar
result
report
vero
cell
express
sui
et
al
although
dcsign
dcsignr
also
function
coreceptor
altern
receptor
sarscov
dock
entri
celltyp
jeffer
et
al
marzi
et
al
yang
et
al
hae
antibodi
dcsign
dcsignr
inhibit
sarscov
infect
suggest
potenti
receptor
either
less
import
viru
entri
ciliat
cell
particular
antibodi
success
block
viru
dock
entri
presenc
function
fig
signific
reduct
sarscov
infect
antisera
support
hypothesi
function
major
receptor
sarscov
infect
ciliat
cell
em
larg
number
viru
particl
releas
infect
cell
bud
vesicl
transport
lumen
surfac
present
insid
ciliat
cell
close
proxim
apic
surfac
ciliat
cell
fig
bf
abund
number
viru
particl
also
trap
cellular
debri
lumen
compart
suggest
cellassoci
viru
might
also
contribut
sarscov
spread
host
mechan
specifi
predomin
polar
releas
sarscov
virion
unclear
releas
viru
particl
lumen
airway
provid
mean
propag
spread
via
interact
potenti
viral
receptor
also
polar
lumen
surfac
ciliat
cell
ie
similar
find
also
report
wang
et
al
recent
report
suggest
also
use
receptor
entri
cell
data
indic
mani
coronavirus
target
pathway
replic
lung
epithelium
hofmann
et
al
em
also
demonstr
extens
cytopatholog
vacuol
infect
cell
suggest
consider
cellassoci
viru
may
shed
infect
patient
fig
f
addit
data
demonstr
sarscov
assembl
releas
occur
via
bud
intern
vesicl
transport
cell
surfac
fig
b
f
ultim
infect
result
shed
ciliat
cell
cell
often
contain
larg
quantiti
viru
fig
f
hae
cultur
model
recapitul
morpholog
featur
human
upper
airway
allow
visual
high
level
replic
destruct
natur
sarscov
also
provid
excel
model
studi
compar
physiolog
respons
lung
larg
number
respiratori
viru
infect
wide
rang
techniqu
avail
determin
effect
respiratori
viru
infect
specif
innat
defens
mechan
airway
epithelium
recapitul
hae
well
ciliat
hae
cultur
mucu
flow
apic
surfac
continu
circular
pattern
due
coordin
activ
cilial
beat
provid
vitro
measur
mucociliari
transport
approxim
mucociliari
clearanc
vivo
fluctuat
flow
rate
measur
observ
rotat
flow
fluoresc
microspher
deposit
apic
surfac
destruct
shed
ciliat
cell
lead
overal
reduct
mucociliari
transport
prevent
upper
airway
effect
clear
viral
pathogen
anoth
import
protect
compon
airway
innat
respons
inhal
pathogen
secret
airway
lumen
highli
glycosyl
mucosubst
eg
surfact
phospholipidprotein
complex
eg
spa
spd
stonebrak
et
al
predict
differ
mucin
speci
distinct
rheolog
innat
defens
function
airway
overal
function
aid
remov
infect
cell
resolv
injur
epithelium
composit
mucosubst
surfact
product
gener
level
product
mucin
surfact
use
predict
diseas
sever
lack
product
follow
viru
infect
lead
reduc
viral
clearanc
greater
sever
diseas
immun
respons
sarscov
assay
sampl
apic
wash
basolater
media
measur
cytokin
interferon
level
note
follow
rsv
infect
mellow
et
al
addit
chang
cellular
mrna
protein
level
determin
transcript
proteom
profil
respect
damag
epithelium
follow
infect
monitor
determin
level
transepitheli
resist
measur
integr
overal
epithelium
well
level
enzym
lactat
dehydrogenas
ldh
indic
tissu
damag
probabl
innat
immun
function
ciliat
cell
critic
diseas
progress
cell
like
repres
initi
target
infect
innat
immun
respons
monitor
hae
cultur
determin
patholog
potenti
wild
type
attenu
respiratori
virus
cultur
make
hae
excel
model
evalu
live
attenu
respiratori
viru
vaccin
replic
pathogen
human
lung
prior
phase
one
trial
live
attenu
vaccin
candid
strain
would
first
assess
human
anim
airway
epitheli
cell
cultur
determin
viral
growth
kinet
low
level
replic
cultur
model
would
consist
limit
replic
airway
anim
model
would
indic
inadequ
vaccin
candid
prior
vivo
studi
anim
hae
cultur
provid
model
system
studi
respiratori
viru
replic
pathogenesi
innat
immun
respons
well
mechan
clearanc
pathogen
human
conduct
airway
sever
paradigm
propos
explain
mechan
spread
sarscov
human
lung
one
model
suggest
sarscov
infect
lung
dendrit
cell
transport
viru
alveolar
region
allow
infect
type
ii
pneumocyt
model
base
studi
dendrit
cell
infect
sarscov
via
interact
express
level
dcsign
marzi
et
al
yang
et
al
altern
model
would
predict
sarscov
infect
spread
could
occur
compon
respiratori
epithelium
inde
consider
earli
patholog
sarscov
observ
bronchiolar
region
demonstr
sarscov
replic
effici
ciliat
cell
isol
nasal
tracheobronchi
airway
region
shown
support
latter
hypothesi
moreov
uniform
gradient
express
throughout
conduct
airway
human
lung
provid
suitabl
substrat
repeat
cycl
viru
amplif
spread
throughout
airway
ultim
spread
cell
compon
alveolu
region
sinc
specif
airway
epitheli
celltyp
especi
ciliat
epitheli
celltyp
possess
uniqu
physiolog
innat
defens
function
lung
import
determin
airway
cell
tropism
sarscov
human
lung
order
understand
patholog
consequ
infect
celltyp
hae
cultur
system
use
examin
replic
pathogenesi
known
respiratori
pathogen
also
excel
tool
amplifi
newli
identifi
emerg
human
virus
may
may
replic
tradit
tissu
cultur
model
multipl
cell
type
hae
cultur
system
provid
addit
target
cell
popul
newli
emerg
virus
cultur
provid
resourc
rapid
amplif
newli
identifi
virus
futur
studi
comparison
studi
human
versu
avian
influenza
strain
human
tracheobronchi
cell
cultur
demonstr
prefer
sialic
acid
speci
respect
viru
actual
resid
differ
cell
type
restrict
amount
replic
avian
viru
make
prior
addit
adapt
potenti
human
host
ibricev
et
al
matrosovich
et
al
airway
cultur
tracheobronchi
cell
rang
anim
speci
also
establish
greatli
increas
number
virus
studi
allow
studi
amplif
zoonot
human
isol
addit
zoonot
virus
passag
human
cultur
identifi
mutat
aris
adapt
provid
uniqu
look
evolut
potenti
human
pathogen
strain
transit
sarscov
zoonot
origin
like
chines
horsesho
bat
anim
chines
market
place
himalayan
palm
civet
cat
raccoon
dog
human
exampl
full
potenti
model
system
util
believ
hae
provid
numer
opportun
studi
pathogenesi
coronavirus
import
human
respiratori
pathogen
model
reflect
much
architectur
human
airway
well
investig
molecular
mechan
govern
viru
cross
speci
transmiss
determin
viral
growth
kinet
icsar
hae
cultur
time
icsar
inocul
onto
apic
surfac
hae
cultur
apic
wash
basolater
media
b
collect
perform
indic
time
wash
serial
dilut
titer
assay
cell
titer
express
pfuml
assess
effect
pretreat
hae
receptor
specif
antisera
growth
kinet
sarscov
infect
hae
pretreat
polyclon
monoclon
antisera
direct
respect
cocktail
monoclon
antisera
direct
dcsign
dcsignr
dcsign
combin
antisera
dcsign
neg
control
antibodi
prior
inocul
icsarscov
apic
wash
indic
time
point
serial
dilut
assay
plaqu
assay
cell
titer
repres
pfuml
determin
viral
growth
kinet
wild
type
sarscov
gfp
virus
three
cell
type
infect
vero
african
green
monkey
kidney
b
african
green
monkey
kidney
c
human
colorect
adenocarcinoma
supernat
aliquot
harvest
indic
time
post
infect
serial
dilut
titer
assay
vero
cell
titer
express
pfuml
diamondsurbani
squaresicsarscov
trianglessarscov
gfp
